RU2014130894A - PEPTID POSSESSING NEUROPROTECTOR AND NOTROPIC ACTIVITY, AND PHARMACEUTICAL COMPOSITION ON ITS BASIS - Google Patents

PEPTID POSSESSING NEUROPROTECTOR AND NOTROPIC ACTIVITY, AND PHARMACEUTICAL COMPOSITION ON ITS BASIS Download PDF

Info

Publication number
RU2014130894A
RU2014130894A RU2014130894/04A RU2014130894A RU2014130894A RU 2014130894 A RU2014130894 A RU 2014130894A RU 2014130894/04 A RU2014130894/04 A RU 2014130894/04A RU 2014130894 A RU2014130894 A RU 2014130894A RU 2014130894 A RU2014130894 A RU 2014130894A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
asn
glu
gly
arg
Prior art date
Application number
RU2014130894/04A
Other languages
Russian (ru)
Other versions
RU2557003C2 (en
Inventor
Анна Пайзеновна Богачук
Зинаида Ивановна Сторожева
Юрий Александрович Золотарев
Георгий Иванович Ковалев
Вячеслав Николаевич Азев
Валерий Михайлович Липкин
Original Assignee
Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) filed Critical Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН)
Priority to RU2014130894/04A priority Critical patent/RU2557003C2/en
Publication of RU2014130894A publication Critical patent/RU2014130894A/en
Application granted granted Critical
Publication of RU2557003C2 publication Critical patent/RU2557003C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1. Пептид формулы Thr-Gly-Glu-Asn-His-Arg-NH, обладающий нейропротекторной и ноотропной активностью.2. Фармацевтическая композиция на основе пептида для профилактики и лечения нейродегенеративных и цереброваскулярных заболеваний, высокоэффективная в низких дозах и используемая в виде капель в нос, состава, г/л:гексапептид Thr-Gly-Glu-Asn-His-Arg-NH2,5нипагин (консервирующее вещество) 1,00хлорид натрия (создает в получаемом раствореосмотическое и онкотическое давление, близкоек таковым показателям плазмы крови)-…………… 10,00карбопол (облегчает проникновение лекарственногосредства через слизистую оболочку) 2,5вода дистиллированная остальное1. The peptide of the formula Thr-Gly-Glu-Asn-His-Arg-NH, with neuroprotective and nootropic activity. Peptide-based pharmaceutical composition for the prevention and treatment of neurodegenerative and cerebrovascular diseases, highly effective in low doses and used as nasal drops, composition, g / l: Thr-Gly-Glu-Asn-His-Arg-NH2,5nipagin hexapeptide (preserving substance) 1.00 sodium chloride (creates osmotic and oncotic pressure in the resulting solution, which is close to those of blood plasma) - …………… 10.00 carbopol (facilitates the penetration of the drug through the mucous membrane) 2.5 water is distilled th rest

Claims (2)

1. Пептид формулы Thr-Gly-Glu-Asn-His-Arg-NH2, обладающий нейропротекторной и ноотропной активностью.1. The peptide of the formula Thr-Gly-Glu-Asn-His-Arg-NH 2 with neuroprotective and nootropic activity. 2. Фармацевтическая композиция на основе пептида для профилактики и лечения нейродегенеративных и цереброваскулярных заболеваний, высокоэффективная в низких дозах и используемая в виде капель в нос, состава, г/л:2. A peptide-based pharmaceutical composition for the prevention and treatment of neurodegenerative and cerebrovascular diseases, highly effective in low doses and used in the form of drops in the nose, composition, g / l: гексапептид Thr-Gly-Glu-Asn-His-Arg-NH2 2,5 hexapeptide Thr-Gly-Glu-Asn-His-Arg-NH 2 2,5 нипагин (консервирующее вещество) 1,00 nipagin (preservative) 1.00 хлорид натрия (создает в получаемом раствореsodium chloride (creates in the resulting solution осмотическое и онкотическое давление, близкое close osmotic and oncotic pressure к таковым показателям плазмы крови)-…………… 10,00  to such indicators of blood plasma) - …………… 10.00 карбопол (облегчает проникновение лекарственногоcarbopol (facilitates drug penetration средства через слизистую оболочку) 2,5 means through the mucous membrane) 2.5 вода дистиллированная остальное distilled water the rest
RU2014130894/04A 2014-07-25 2014-07-25 Peptide having neuroprotective and nootropic activity and pharmaceutical composition based thereon RU2557003C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2014130894/04A RU2557003C2 (en) 2014-07-25 2014-07-25 Peptide having neuroprotective and nootropic activity and pharmaceutical composition based thereon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2014130894/04A RU2557003C2 (en) 2014-07-25 2014-07-25 Peptide having neuroprotective and nootropic activity and pharmaceutical composition based thereon

Publications (2)

Publication Number Publication Date
RU2014130894A true RU2014130894A (en) 2014-10-20
RU2557003C2 RU2557003C2 (en) 2015-07-20

Family

ID=53380316

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014130894/04A RU2557003C2 (en) 2014-07-25 2014-07-25 Peptide having neuroprotective and nootropic activity and pharmaceutical composition based thereon

Country Status (1)

Country Link
RU (1) RU2557003C2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2662429C1 (en) * 2017-08-01 2018-07-26 Общество с ограниченной ответственностью "Нейропепт" Peptide with neuroprotective activity on model of mftp-induced parkinsonism and a pharmaceutical composition on its basis
RU2682039C1 (en) * 2018-05-23 2019-03-14 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Peptide, possessing anti-tumor and anti-metastatic activity, and finished dosage form based thereon
RU2704621C1 (en) * 2018-08-01 2019-10-30 Евгений Владимирович Зиновьев Pharmaceutical composition for treating burn skin lesions
RU2743293C1 (en) * 2020-07-06 2021-02-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Use of Gly-His-Lys-Val-Glu-Pro peptide to improve learning abilty and memory.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053626A1 (en) * 1999-03-11 2000-09-14 Institut Bioorganicheskoi Khimii Imeni Akademikov M.M.Shemyakina I Ju.A.Ovchinnikova Rossiiskoi A Kademii Nauk Peptide having an antitumoral, protection and normalisation activity and pharmaceutical composition

Also Published As

Publication number Publication date
RU2557003C2 (en) 2015-07-20

Similar Documents

Publication Publication Date Title
HRP20190777T1 (en) Rapid-acting insulin compositions
WO2015183963A3 (en) Therapeutic compositions including redox-active parabenzoquinones and uses thereof
RU2014130894A (en) PEPTID POSSESSING NEUROPROTECTOR AND NOTROPIC ACTIVITY, AND PHARMACEUTICAL COMPOSITION ON ITS BASIS
ECSP16084317A (en) PHARMACEUTICAL FORMULATIONS, PREPARATION PROCESSES AND METHODS OF USE
WO2014165607A3 (en) Aromatic-cationic peptide formulations, compositions and methods of use
WO2015183995A3 (en) Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
EA201500061A1 (en) PHARMACEUTICAL COMPOSITION FOR THERAPY FOR PULMONARY FORMS OF HIGH-DISTANCE DISEASE, CAUSED BY OXYGEN FASTENGEN AND REDUCED ATMOSPHERIC PRESSURE
CO2020008308A2 (en) Modified lipidated relaxin b-chain peptides and their therapeutic use
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment
AR114324A1 (en) MODIFIED LIPIDED RELAXIN B-CHAIN PEPTIDES AND THEIR THERAPEUTIC USE
BR112019002719A2 (en) acetyl leucine, or a pharmaceutically acceptable salt thereof, for use in methods related to lysosomal deposition diseases
MX2019008489A (en) Treatment comprising oral or gastric administration of edaravone.
AU2015242791A1 (en) Drug Delivery Enhancer Comprising Substance For Activating Lysophospholipid Receptors
AR114323A1 (en) MODIFIED RELAXIN B-CHAIN PEPTIDES AND THEIR THERAPEUTIC USE
WO2014164285A3 (en) Use of levocetirizine and montelukast in the treatment of vasculitis
BR112015021265A2 (en) enhancement methods of use for recombinant human secretoglobins
BR112017001695A2 (en) combination therapy
PE20210123A1 (en) METHYLLACTAM RING COMPOUND AND PHARMACEUTICAL USE OF THE SAME
MX2018005363A (en) Pharmaceutical composition intended to be administred to nasal mucosa.
RU2014117294A (en) 4,6-DI (3,12-DIAZA-6,9-DIAZONIADISPIRO [5.2.5.2] HEXADECAN-1-IL) -2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE DIHYDROCHLORIDE HEXAHYDRATE FOR THE TREATMENT OF CHEMISE
AR097613A1 (en) DOSAGE OF GIP / GLP-1 CO-ANTAGONIST PEPTIDES FOR HUMAN ADMINISTRATION
EA201501130A1 (en) OPHTHALMOLOGIC PHARMACEUTICAL COMPOSITION
PH12016501500B1 (en) Topical formulations of heparin
RU2013105211A (en) APPLICATION OF TERAPEPTIDE Arg-Pro-Gly-Pro AS A MEANS FOR PREVENTION AND TREATMENT OF HYPERCHOLESTERINEMIA, METHOD FOR PREVENTION AND TREATMENT OF HYPERCHOLESTEREMIA, PHARMACEUTICAL CHEMISTROSIS
CL2018003269A1 (en) Carboxylic acids for application in early childhood.

Legal Events

Date Code Title Description
QB4A Licence on use of patent

Free format text: LICENCE

Effective date: 20170515